Paperbase

Immunogenic membrane-associated proteins of Mycobacterium tuberculosis revealed by proteomics

Sinha, S. Kosalai, K. Arora, S. Namane, A. Sharma, P. Gaikwad, A. N. Brodin, P. Cole, S. T.

Microbiology (Reading, England), 2005-7

https://doi.org/10.1099/mic.0.27799-0

Sudhir Sinha

Sinha Sudhir

ORCID: 0000-0003-3149-1116

S-Enantiomer of the Antitubercular Compound S006-830 Complements Activity of Frontline TB Drugs and Targets Biogenesis of Mycobacterium tuberculosis Cell Envelope 10.1021/acsomega.7b01281

Correction to “S-Enantiomer of the Antitubercular Compound S006-830 Complements Activity of Frontline TB Drugs and Targets Biogenesis of Mycobacterium tuberculosis Cell Envelope” 10.1021/acsomega.7b01966

Synergy between tuberculin skin test and proliferative T cell responses to PPD or cellmembrane antigens of Mycobacterium tuberculosis for detection of latent TB infection in a high disease-burden setting 10.1371/journal.pone.0204429

Synthesis and anti-tubercular activity of conformationally-constrained and bisquinoline analogs of TMC207 10.1039/c5md00131e

Tetrahydrofuran amino acid-containing gramicidin S analogues with improved biological profiles 10.1039/c5ob00622h

Erratum: Stereoselective total synthesis of Jaspine B (Pachastrissamine) utilizing iodocyclization and an investigation of its cytotoxic activity (Tetrahedron: Asymmetry 24 (2013) (903-908)) 10.1016/j.tetasy.2013.09.013

Semi-quantitative detection of Mycobacterium leprae antigens in skin scrapings: suitability as a laboratory aid for field diagnosis of leprosy 10.1016/j.trstmh.2007.02.026

Caution when standardizing serum antibody competition assays 10.1016/0035-9203(90)90408-7

Stereoselective total synthesis of Jaspine B (Pachastrissamine) utilizing iodocyclization and an investigation of its cytotoxic activity 10.1016/j.tetasy.2013.07.003

C-3 alkyl/arylalkyl-2,3-dideoxy hex-2-enopyranosides as antitubercular agents: Synthesis, biological evaluation, and QSAR study 10.1021/jm070110h

Low molecular weight proteins of outer membrane of Salmonella typhimurium are immunogenic in Salmonella induced reactive arthritis revealed by proteomics 10.1111/j.1365-2249.2007.03362.x

Syntheses of novel antimycobacterial combinatorial libraries of structurally diverse substituted pyrimidines by three-component solid-phase reactions 10.1016/S0960-894X(01)00829-0

Thiophene containing trisubstituted methanes [TRSMs] as identified lead against Mycobacterium tuberculosis 10.1016/j.ejmech.2015.03.036

Additional synthesis on thiophene-containing trisubstituted methanes (TRSMs) as inhibitors of M-tuberculosis and 3D-QSAR studies 10.1080/1062936X.2016.1243575

Naturally produced opsonizing antibodies restrict the survival of Mycobacterium tuberculosis in human macrophages by augmenting phagosome maturation 10.1098/rsob.150171

Application of Huisgen (3 + 2) cycloaddition reaction: Synthesis of 1-(2,3-dihydrobenzofuran-2-yl-methyl [1,2,3]-triazoles and their antitubercular evaluations 10.1016/j.ejmech.2009.09.036

A comparative evaluation of serological assays for lepromatous leprosy 10.5935/0305-7518.19880024

Synthesis, Conformational Studies and Biological Profiles of Tetrahydrofuran Amino-Acid-Containing Cationic Antitubercular Peptides 10.1002/ajoc.201700183

Solid support synthesis of 6-aryl-2-substituted pyrimidin-4-yl phenols as anti-infective agents 10.1016/j.bmcl.2005.08.020

Regioselective synthesis of densely functionalized, enantiopure, sugar-pyrazole hybrids as potential scaffolds for drug discovery 10.1039/c3ra22287j

A major T-cell-inducing cytosolic 23 kDa protein antigen of the vaccine candidate Mycobacterium habana is superoxide dismutase 10.1099/13500872-142-6-1375

Selective reactivity of 2-mercaptoethanol with 5β,6β-epoxide in steroids from Withania somnifera 10.1016/j.steroids.2007.10.006

Search of antitubercular activities in tetrahydroacridines: Synthesis and biological evaluation 10.1016/j.bmcl.2006.07.025

Preparation and reactions of sugar azides with alkynes: synthesis of sugar triazoles as antitubercular agents 10.1016/j.carres.2008.02.013

Synthesis and antitubercular activity of substituted phenylmethyl- and pyridylmethyl amines 10.1016/j.bmc.2006.09.020

An efficient synthesis of aryloxyphenyl cyclopropyl methanones: A new class of anti-mycobacterial agents 10.1016/j.bmcl.2005.07.007

Novel, potent, orally bioavailable and selective mycobacterial ATP synthase inhibitors that demonstrated activity against both replicating and non-replicating M. tuberculosis 10.1016/j.bmc.2014.12.060

Immunohistologic comparison between armadillo-derived leprosin and standard lepromin skin tests in leprosy patients 10.1159/000234187

Synthesis of glycosylated β-amino acids as new class of antitubercular agents 10.1016/S0223-5234(02)01398-3

Synthesis, molecular modeling and bio-evaluation of cycloalkyl fused 2-aminopyrimidines as antitubercular and antidiabetic agents 10.1016/j.bmcl.2011.06.040

Synthesis of galactopyranosyl amino alcohols as a new class of antitubercular and antifungal agents 10.1016/j.bmcl.2003.11.020

Substituted hydrazinecarbothioamide as potent antitubercular agents: Synthesis and quantitative structure-activity relationship (QSAR) 10.1016/j.bmcl.2010.02.081

Knowledge based identification of potent antitubercular compounds using structure based virtual screening and structure interaction fingerprints 10.1021/ci8003607

Synthesis and evaluation of antitubercular activity of glycosyl thio- and sulfonyl acetamide derivatives 10.1016/j.bmcl.2008.06.004

Artemisinin-derived stable ozonides: Synthesis and antitubercular activities 10.1007/s00044-006-1504-9

Higher acyclic nitrogen containing deoxy sugar derivatives: A new lead in the generation of antimycobacterial chemotherapeutics 10.1016/S0968-0896(02)00045-7

Effect of substituents on diarylmethanes for antitubercular activity 10.1016/j.ejmech.2006.09.020

A small library of trisubstituted pyrimidines as antimalarial and antitubercular agents 10.1016/j.bmcl.2005.08.053

Novel aryloxy azolyl chalcones with potent activity against Mycobacterium tuberculosis H37Rv 10.1016/j.ejmech.2011.06.037

Anti-tumour activity of a novel coumarin-chalcone hybrid is mediated through intrinsic apoptotic pathway by inducing PUMA and altering Bax/Bcl-2 ratio 10.1007/s10495-014-0975-2

A facile synthesis of α,α′-(EE)-bis(benzylidene)-cycloalkanones and their antitubercular evaluations 10.1016/j.ejmech.2008.09.026

Cassane Diterpenes from Caesalpinia bonduc 10.1016/j.phytochem.2008.12.008

Enhancement of human T cell response to a peptide epitope of 38 kDa antigen of Mycobacterium tuberculosis by liposomes 10.1081/IPH-120003757

Immunoreactive antigens of a candidate leprosy vaccine: Mycobacterium habana 10.5935/0305-7518.19950005

Induction of Th1-type cellular responses in cured/exposed Leishmania-infected patients and hamsters against polyproteins of soluble Leishmania donovani promastigotes ranging from 89.9 to 97.1 kDa 10.1016/j.vaccine.2008.06.102

Staurosporine induces apoptosis in human papillomavirus positive oral cancer cells at G2/M phase by disrupting mitochondrial membrane potential and modulation of cell cytoskeleton 10.1016/j.oraloncology.2009.04.009

Antiproliferative action of Xylopia aethiopica fruit extract on human cervical cancer cells 10.1002/ptr.3551

Antigenic definition of plasma membrane proteins of Bacillus Calmette- Guerin: Predominant activation of human T cells by low-molecular-mass integral proteins 10.1046/j.1365-3083.1999.00616.x

Synthesis and in vitro evaluation of novel coumarin-chalcone hybrids as potential anticancer agents 10.1016/j.bmcl.2010.10.116

Picroliv, the iridoid glycoside fraction of Picrorhiza kurroa, selectively augments human T cell response to mycobacterial protein antigens 10.3109/08923979809031518

Synthesis and antitubercular activity of 2-hydroxy-aminoalkyl derivatives of diaryloxy methano phenanthrenes 10.1016/j.bmcl.2005.08.045

Synthesis and antitubercular activities of bis-glycosylated diamino alcohols 10.1016/j.bmc.2005.05.021

Baylis-Hillman reaction: Convenient ascending syntheses and biological evaluation of acyclic deoxy monosaccharides as potential antimycobacterial agents 10.1016/S0968-0896(02)00210-9

Urinary haptoglobin, alpha-1 anti-chymotrypsin and retinol binding protein identified by proteomics as potential biomarkers for lupus nephritis 10.1111/cei.12930

Immunogenic membrane-associated proteins of Mycobacterium tuberculosis revealed by proteomics 10.1099/mic.0.27799-0

Proteomic approach for identification and characterization of novel immunostimulatory proteins from soluble antigens of Leishmania donovani promastigotes 10.1002/pmic.200600725

Synthesis and cytotoxicity evaluation of (tetrahydro-β-carboline)-1,3,5-triazine hybrids as anticancer agents 10.1016/j.ejmech.2010.02.001

Solution-phase synthesis of a library of carbapeptide analogues based on glycosylamino acid scaffolds and their in silico screening and antimicrobial evaluation 10.1021/cc800206m

Microparticles induce variable levels of activation in macrophages infected with Mycobacterium tuberculosis 10.1016/j.tube.2010.03.001

Synthesis and anti-tubercular activities of benzo[4,5]furo[2,3-c] chromen - 6-one derivatives 10.2174/2211362611201010006

Discovery of new 1,3,5-triazine scaffolds with potent activityagainst Mycobacterium tuberculosis H37Rv 10.1016/j.ejmech.2010.04.017

Design, synthesis and antitubercular activity of diarylmethylnaphthol derivatives 10.1016/j.bmcl.2007.07.089

Proteome analysis of the plasma membrane of Mycobacterium tuberculosis 10.1002/cfg.211

Urinary osteoprotegerin: A potential biomarker of lupus nephritis disease activity 10.1177/0961203316636470

Stable Tricyclic Antitubercular Ozonides Derived from Artemisinin 10.1021/acs.orglett.5b02296

Synthesis and antimycobacterial activities of glycosylated amino alcohols and amines 10.1016/j.ejmech.2004.12.002

Comparative efficacy of biodegradable liposomes and microspheres as carriers for delivery of Vibrio cholerae antigens in the intestine 10.1016/0264-410X(94)90146-5

Prophylactic efficacy of high-molecular-weight antigenic fractions of a recent clinical isolate of Leishmania donovani against visceral leishmaniasis 10.1111/j.1365-3083.2008.02171.x

Coupling of proteins to liposomes and their role in understanding delayed type of hypersensitivity in human and mice 10.1007/BF02703891

Melatonin reverses fas, E2F-1 and endoplasmic reticulum stress mediated apoptosis and dysregulation of autophagy induced by the herbicide atrazine in murine splenocytes 10.1371/journal.pone.0108602

Natural product inspired diversity oriented synthesis of tetrahydroquinoline scaffolds as antitubercular agent 10.1021/co100022h

Fractionation of mycobacterial integral membrane proteins by continuous elution SDS-PAGE reveals the immunodominance of low molecular weight subunits for human T cells 10.1046/j.1365-2249.1997.4531351.x

Association of mycobacterial-specific and Mycobacterium leprae specific antibody levels with clinical activity in tuberculoid leprosy: A comparative study of three serological enzyme-immunoassays 10.5935/0305-7518.19910014

Chloropyrimidines as a new class of antimicrobial agents 10.1016/S0968-0896(01)00374-1

Evaluation of Mycobacterium smegmatis as a possible surrogate screen for selecting molecules active against multi-drug resistant Mycobacterium tuberculosis 10.2323/jgam.53.333

A serological test for leprosy based on competitive inhibition of monoclonal antibody binding to the MY2a determinant of Mycobacterium leprae 10.1016/0035-9203(83)90309-7

Cytotoxic clerodane diterpenoids from the leaves of Polyalthia longifolia 10.1080/10236240902765301

Determinants of natural immunity against tuberculosis in an endemic setting: Factors operating at the level of macrophage-Mycobacterium tuberculosis interaction 10.1111/j.1365-2249.2007.03585.x

Synthesis and antitubercular screening of imidazole derivatives 10.1016/j.ejmech.2009.02.013

The detection of subclinical leprosy using a monoclonal antibody based radioimmunoassay 10.5935/0305-7518.19860025

Inhibition of platelet aggregation by rat globin 10.1016/S0049-3848(02)00346-8

Corrigendum to "Novel, potent, orally bioavailable and selective mycobacterial ATP synthase inhibitors that demonstrated activity against both replicating and non-replicating M. tuberculosis" [Bioorg. Med. Chem. 23 (2015) 742-752] 10.1016/j.bmc.2015.04.039

Diastereoselective one-pot Wittig olefination-Michael addition and olefin cross metathesis strategy for total synthesis of cytotoxic natural product (+)-varitriol and its higher analogues 10.1039/c1ob06039b

Thiophene containing triarylmethanes as antitubercular agents 10.1016/j.bmcl.2007.10.083

Search of antimycobacterial activities in hybrid molecules with benzopyran skeleton 10.1007/s00044-010-9402-6

Synthesis and optimization of antitubercular activities in a series of 4-(aryloxy)phenyl cyclopropyl methanols 10.1016/j.ejmech.2010.09.063

Synthesis and bio-evaluation of alkylaminoaryl phenyl cyclopropyl methanones as antitubercular and antimalarial agents 10.1016/j.bmc.2010.09.071

Immune responses to Mycobacterium tuberculosis membrane-associated antigens including alpha crystallin can potentially discriminate between latent infection and active tuberculosis disease 10.1371/journal.pone.0228359

Patterns of T and B cell responses to Mycobacterium tuberculosis membrane-associated antigens and their relationship with disease activity in rheumatoid arthritis patients with latent tuberculosis infection 10.1371/journal.pone.0255639

MANTOUX TEST IS INADEQUATE TO DEFINE ALL SUBJECTS WITH LATENT TUBERCULAR INFECTION 10.1136/ANNRHEUMDIS-2018-EULAR.6919

Specificity and function of immunogenic peptides from the 35-kilodalton protein of Mycobacterium leprae 10.1128/IAI.67.3.1501-1504.1999

DETECTION OF MYCOBACTERIAL ANTIGENS IN LEPROSY SERUM IMMUNE-COMPLEX 10.1128/JCM.24.1.169-171.1986

Serological distinction of integral plasma membrane proteins as a class of mycobacterial antigens and their relevance for human T cell activation 10.1111/J.1365-2249.1995.TB03863.X

Synthesis and biological evaluation of 4-thiazolidinone derivatives as potential antimycobacterial agents 10.3998/ARK.5550190.0006.209

Priscille Brodin

Brodin Priscille

ORCID: 0000-0003-0991-7344

Email: priscille.brodin@inserm.fr

How can nanoparticles contribute to antituberculosis therapy? 10.1016/j.drudis.2017.01.011

Host-directed therapies offer novel opportunities for the fight against tuberculosis 10.1016/j.drudis.2017.05.005

A Bacterial Toxin with Analgesic Properties: Hyperpolarization of DRG Neurons by Mycolactone 10.3390/toxins9070227

A Bacterial Toxin with Analgesic Properties: Hyperpolarization of DRG Neurons by Mycolactone 10.3390/toxins9070227 10.3390/toxins9070227.

Clofazimine encapsulation in nanoporous silica particles for the oral treatment of antibiotic-resistant Mycobacterium tuberculosis infections 10.2217/nnm-2016-0364

Cyclodextrin-based nanocarriers containing a synergic drug combination: a potential formulation for pulmonary administration of antitubercular drugs 10.1016/j.ijpharm.2017.05.030 10.1016/j.ijpharm.2017.05.030.

Genome-wide, high-content siRNA screening identifies the Alzheimer's genetic risk factor FERMT2 as a major modulator of APP metabolism 10.1007/s00401-016-1652-z

Host-directed therapies offer novel opportunities for the fight against tuberculosis 10.1016/j.drudis.2017.05.005 10.1016/j.drudis.2017.05.005.

Identification of aminopyrimidine-sulfonamides as potent modulators of Wag31-mediated cell elongation in mycobacteria 10.1111/mmi.13535

Impact of pe_ pgrs33 Gene Polymorphisms on Mycobacterium tuberculosis Infection and Pathogenesis 10.3389/fcimb.2017.00137

LppM impact on the colonization of macrophages by Mycobacterium tuberculosis 10.1111/cmi.12619

Phenotypic assays for Mycobacterium tuberculosis infection 10.1002/cyto.a.23129 10.1002/cyto.a.23129.

Reversion of antibiotic resistance in Mycobacterium tuberculosis by spiroisoxazoline SMARt-420 10.1126/science.aag1006

A fragment merging approach towards the development of small molecule inhibitors of Mycobacterium tuberculosis EthR for use as ethionamide boosters 10.1039/c5ob02630j

Khaya grandifoliola C.DC: a potential source of active ingredients against hepatitis C virus in vitro 10.1007/s00705-016-2771-5

Mycobacterium tuberculosis LppM Displays an Original Structure and Domain Composition Linked to a Dual Localization 10.1016/j.str.2016.07.009

Mycolactone The amazing analgesic mycobacterial toxin 10.1051/medsci/20163202007

STAT3 Represses Nitric Oxide Synthesis in Human Macrophages upon Mycobacterium tuberculosis Infection 10.1038/srep29297

2-Carboxyquinoxalines Kill Mycobacterium tuberculosis through Noncovalent Inhibition of DprE1 10.1021/cb5007163

Cytosolic Access of Mycobacterium tuberculosis: Critical Impact of Phagosomal Acidification Control and Demonstration of Occurrence In Vivo 10.1371/journal.ppat.1004650

High content screening in chemical biology: overview and main challenges 10.1051/medsci/20153102016

High-Content Screening Technology Combined with a Human Granuloma Model as a New Approach To Evaluate the Activities of Drugs against Mycobacterium tuberculosis 10.1128/aac.03705-14

Increased protective efficacy of recombinant BCG strains expressing virulence-neutral proteins of the ESX-1 secretion system 10.1016/j.vaccine.2015.03.083

Plant extracts from Cameroonian medicinal plants strongly inhibit hepatitis C virus infection in vitro 10.3389/fmicb.2015.00438

Polyphenols Inhibit Hepatitis C Virus Entry by a New Mechanism of Action 10.1128/jvi.01473-15

Testing chemical and genetic Modulators in Mycobacterium tuberculosis infected cells using phenotypic assays 10.1007/978-1-4939-2450-9_24

A Microscopic Phenotypic Assay for the Quantification of Intracellular Mycobacteria Adapted for High-throughput/High-content Screening 10.3791/51114

Ligand Efficiency Driven Design of New Inhibitors of Mycobacterium tuberculosis Transcriptional Repressor EthR Using Fragment Growing, Merging, and Linking Approaches 10.1021/jm500422b

Mycobacterial Toxin Induces Analgesia in Buruli Ulcer by Targeting the Angiotensin Pathways 10.1016/j.cell.2014.04.040

Potent antiviral activity of Solanum rantonnetii and the isolated compounds against hepatitis C virus in vitro 10.1016/j.jff.2014.09.022

A novel specific edge effect correction method for RNA interference screenings 10.1093/bioinformatics/btr648

Discovery of Novel N-Phenylphenoxyacetamide Derivatives as EthR Inhibitors and Ethionamide Boosters by Combining High-Throughput Screening and Synthesis 10.1021/jm3003779

Ethionamide Boosters. 2. Combining Bioisosteric Replacement and Structure-Based Drug Design To Solve Pharmacokinetic Issues in a Series of Potent 1,2,4-Oxadiazole EthR Inhibitors 10.1021/jm200825u

The Balance of Apoptotic and Necrotic Cell Death in Mycobacterium tuberculosis Infected Macrophages Is Not Dependent on Bacterial Virulence 10.1371/journal.pone.0047573

Analogous Mechanisms of Resistance to Benzothiazinones and Dinitrobenzamides in Mycobacterium smegmatis 10.1371/journal.pone.0026675

Ethionamide Boosters: Synthesis, Biological Activity, and Structure-Activity Relationships of a Series of 1,2,4-Oxadiazole EthR Inhibitors 10.1021/jm200076a

High-content screening in infectious diseases 10.1016/j.cbpa.2011.05.023

Functional characterization of the Mycobacterium tuberculosis serine/threonine kinase PknJ 10.1099/mic.0.038133-0

High Content Phenotypic Cell-Based Visual Screen Identifies Mycobacterium tuberculosis Acyltrehalose-Containing Glycolipids Involved in Phagosome Remodeling 10.1371/journal.ppat.1001100

High-content imaging of Mycobacterium tuberculosis-infected macrophages: an in vitro model for tuberculosis drug discovery 10.4155/fmc.10.223

Long-circulating DNA lipid nanocapsules as new vector for passive tumor targeting 10.1016/j.biomaterials.2009.09.044

Automated High-Throughput siRNA Transfection in Raw 264.7 Macrophages: A Case Study for Optimization Procedure 10.1177/1087057108328762

Benzothiazinones Kill Mycobacterium tuberculosis by Blocking Arabinan Synthesis 10.1126/science.1171583

High Content Screening Identifies Decaprenyl-Phosphoribose 2 ' Epimerase as a Target for Intracellular Antimycobacterial Inhibitors 10.1371/journal.ppat.1000645

Systematic Genetic Nomenclature for Type VII Secretion Systems 10.1371/journal.ppat.1000507

Control of M-tuberculosis ESAT-6 secretion and specific T cell recognition by PhoP 10.1371/journal.ppat.0040033

Aquatic insects and transmission of Mycobacterium ulcerans 10.1051/medsci/20072367572

ESAT-6 from Mycobacterium tuberculosis dissociates from its putative chaperone CFP-10 under acidic conditions and exhibits membrane-lysing activity 10.1128/jb.00469-07

Impact of Mycobacterium ulcerans biofilm on transmissibility to ecological niches and Buruli ulcer pathogenesis 10.1371/journal.ppat.0030062

Protection against mycobacterium ulcerans lesion development by exposure to aquatic insect saliva 10.1371/journal.pmed.0040064

Support vector machines for automatic detection of tuberculosis bacteria in confocal microscopy images 10.1109/isbi.2007.356794

Synthesis and antimycobacterial evaluation of benzofurobenzopyran analogues 10.1016/j.bmc.2006.12.009

An increase in antimycobacterial Th1-cell responses by prime-boost protocols of immunization does not enhance protection against tuberculosis 10.1128/iai.74.4.2128-2137.2006

Benzofuro 3,2-f 1 benzopyrans: A new class of antitubercular agents 10.1016/j.bmc.2006.03.033

Dissection of ESAT-6 system 1 of Mycobacterium tuberculosis and impact on immunogenicity and virulence 10.1128/iai.74.1.88-98.2006

High frequency of CD4(+) T cells specific for the TB10.4 protein correlates with protection against Mycobacterium tuberculosis infection 10.1128/iai.02086-05

Inactivation of Rv2525c, a substrate of the twin arginine translocation (Tat) system of Mycobacterium tuberculosis, increases beta-lactam susceptibility and virulence 10.1128/jb.00631-06

Evaluation of vaccines in the EU TB vaccine cluster using a guinea pig aerosol infection model of tuberculosis 10.1016/j.tube.2004.09.009

Functional analysis of early secreted antigenic target-6, the dominant T-cell antigen of Mycobacterium tuberculosis, reveals key residues involved in secretion, complex formation, virulence, and immunogenicity 10.1074/jbc.M503515200

Immunogenic membrane-associated proteins of Mycobacterium tuberculosis revealed by proteomics 10.1099/mic.0.27799-0

Proteomic identification of M. tuberculosis protein kinase substrates: PknB recruits GarA, a FHA domain-containing protein, through activation loop-mediated interactions 10.1016/j.jmb.2005.05.049

Tuberculosis: from genome to vaccine 10.1586/14760584.4.4.541

Cell envelope protein PPE68 contributes to Mycobacterium tuberculosis RDI immunogenicity independently of a 10-kilodalton culture filtrate protein and ESAT-6 10.1128/iai.72.4.2170-2176.2004

Enhanced protection against tuberculosis by vaccination with recombinant Mycobacterium microti vaccine that induces T cell immunity against region of difference 1 antigens 10.1086/421468

ESAT-6 proteins: protective antigens and virulence factors? 10.1016/j.tim.2004.09.007

Macro-array and bioinformatic analyses reveal mycobacterial 'core' genes, variation in the ESAT-6 gene family and new phylogenetic markers for the Mycobacterium tuberculosis complex 10.1099/mic.0.26662-0

CD8(+)-T-cell responses of mycobacterium-infected mice to a newly identified major histocompatibility complex class I-restricted epitope shared by proteins of the ESAT-6 family 10.1128/iai.71.12.7173-7177.2003

Recombinant BCG exporting ESAT-6 confers enhanced protection against tuberculosis 10.1038/nm859

A new evolutionary scenario for the Mycobacterium tuberculosis complex 10.1073/pnas.052548299

Bacterial artificial chromosome-based comparative genomic analysis identifies Mycobacterium microti as a natural ESAT-6 deletion mutant 10.1128/iai.70.10.5568-5578.2002

Disruption of HIV-1 integrase-DNA complexes by short 6-oxocytosine-containing oligonucleotides 10.1021/bi015732y

Loss of RD1 contributed to the attenuation of the live tuberculosis vaccines Mycobacterium bovis BCG and Mycobacterium microti 10.1046/j.1365-2958.2002.03237.x

6-Oxocytidine containing oligonucleotides inhibit the HIV-1 integrase in vitro 10.1081/ncn-100002322

Determinants of Mg2+-dependent activities of recombinant human immunodeficiency virus type 1 integrase 10.1021/bi000398b

Inhibition of the human immunodeficiency virus type 1 DNA integration by modified oligonucleotides 10.1023/a:1026631910681

Branched oligonucleotide-intercalator conjugate forming a parallel stranded structure inhibits HIV-1 integrase 10.1016/s0014-5793(99)01350-2

Inhibition of HIV-1 integration by mono- & bi-functionalized triple helix forming oligonucleotides 10.1080/07328319908044831

Optimization of alternate-strand triple helix formation at the 5 '-TpA-3 ' and 5 '-ApT-3 ' junctions 10.1093/nar/27.15.3029

A truncated HIV-1 Tat protein basic domain rapidly translocates through the plasma membrane and accumulates in the cell nucleus 10.1074/jbc.272.25.16010

Mycobacterium tuberculosis inhibits human innate immune responses via the production of TLR2 antagonist glycolipids 10.1073/pnas.1707840114

ArfGAP1 restricts Mycobacterium tuberculosis entry by controlling the actin cytoskeleton 10.15252/embr.201744371

ArfGAP1 restricts Mycobacterium tuberculosis entry by controlling the actin cytoskeleton 10.15252/embr.201744371 10.15252/embr.201744371.

Combination therapy for tuberculosis treatment: pulmonary administration of ethionamide and booster co-loaded nanoparticles 10.1038/s41598-017-05453-3

Cyclipostins and Cyclophostin analogs as promising compounds in the fight against tuberculosis 10.1038/s41598-017-11843-4 10.1038/s41598-017-11843-4.

Fragment-Sized EthR Inhibitors Exhibit Exceptionally Strong Ethionamide Boosting Effect in Whole-Cell Mycobacterium tuberculosis Assays 10.1021/acschembio.7b00091

Host-pathogen systems for early drug discovery against tuberculosis 10.1016/j.mib.2017.11.017 10.1016/j.mib.2017.11.017.

Legionella pneumophila Modulates Mitochondrial Dynamics to Trigger Metabolic Repurposing of Infected Macrophages 10.1016/j.chom.2017.07.020 10.1016/j.chom.2017.07.020. Epub 2017 Aug 31.

Mycobacterium tuberculosis Controls Phagosomal Acidification by Targeting CISH-Mediated Signaling 10.1016/j.celrep.2017.08.101 10.1016/j.celrep.2017.08.101.

Mycobacterium tuberculosis inhibits human innate immune responses via the production of TLR2 antagonist glycolipids 10.1073/pnas.1707840114 10.1073/pnas.1707840114.

Identification of Piperazinylbenzenesulfonamides as New Inhibitors of Claudin-1 Trafficking and Hepatitis C Virus Entry 10.1128/jvi.01982-17

Multiplexed Quantitation of Intraphagocyte Mycobacterium tuberculosis Secreted Protein Effectors 10.1016/j.celrep.2018.03.125

Oxadiazolone derivatives, new promising multi-target inhibitors against M. tuberculosis 10.1016/j.bioorg.2018.08.025

Proteomics of Mycobacterium infection: Moving towards a Better Understanding of Pathogen-Driven immunomodulation 10.3389/fimmu.2018.00086

Synergy between circular bacteriocin AS-48 and ethambutol against Mycobacterium tuberculosis 10.1128/aac.00359-18

The EU approved antimalarial pyronaridine shows antitubercular activity and synergy with rifampicin, targeting RNA polymerase 10.1016/j.tube.2018.08.004

Cyclipostins and Cyclophostin analogs as promising compounds in the fight against tuberculosis 10.1038/s41598-017-11843-4

Cyclodextrin-based nanocarriers containing a synergic drug combination: A potential formulation for pulmonary administration of antitubercular drugs 10.1016/j.ijpharm.2017.05.030

Host-pathogen systems for early drug discovery against tuberculosis 10.1016/j.mib.2017.11.017

Legionella pneumophila Modulates Mitochondrial Dynamics to Trigger Metabolic Repurposing of Infected Macrophages 10.1016/j.chom.2017.07.020

Mycobacterium tuberculosis Controls Phagosomal Acidification by Targeting CISH-Mediated Signaling 10.1016/j.celrep.2017.08.101

Phenotypic assays for Mycobacterium tuberculosis infection 10.1002/cyto.a.23129

A fast, fully automated cell segmentation algorithm for high-throughput and high-content screening 10.1002/cyto.a.20627

Compartmentalized Encapsulation of Two Antibiotics in Porous Nanoparticles: an Efficient Strategy to Treat Intracellular Infections 10.1002/ppsc.201800360

Spatiotemporal Changes of the Phagosomal Proteome in Dendritic Cells in Response to LPS Stimulation 10.1074/mcp.RA119.001316

Mycolactone as Analgesic: Subcutaneous Bioavailability Parameters 10.3389/fphar.2019.00378

Intrinsic Antibacterial Activity of Nanoparticles Made of β-Cyclodextrins Potentiates Their Effect as Drug Nanocarriers against Tuberculosis 10.1021/acsnano.8b07902

Mitochondrial Dynamics and Activity in Legionella-Infected Cells 10.1007/978-1-4939-9048-1_13

Heparin-Binding Hemagglutinin Adhesin (HBHA) Is Involved in Intracytosolic Lipid Inclusions Formation in Mycobacteria 10.3389/fmicb.2018.02258

Dehydrojuncusol, a Natural Phenanthrene Compound Extracted from Juncus maritimus, Is a New Inhibitor of Hepatitis C Virus RNA Replication 10.1128/jvi.02009-18

A novel codrug made of the combination of ethionamide and its potentiating booster: synthesis, self-assembly into nanoparticles and antimycobacterial evaluation 10.1039/C9OB00680J

Could Mycolactone Inspire New Potent Analgesics? Perspectives and Pitfalls 10.3390/toxins11090516

Paradoxical Roles of the MAL/Tirap Adaptor in Pathologies. 10.3389/fimmu.2020.569127

Fragment-Based Optimized EthR Inhibitors with in Vivo Ethionamide Boosting Activity. 10.1021/acsinfecdis.9b00277

Intracellular and in vivo evaluation of imidazo[2,1-b]thiazole-5-carboxamide anti-tuberculosis compounds. 10.1371/journal.pone.0227224

Preclinical assessment of a new live attenuated Mycobacterium tuberculosis Beijing-based vaccine for tuberculosis. 10.1016/j.vaccine.2019.11.085

IRG1 controls immunometabolic host response and restricts intracellular Mycobacterium tuberculosis infection 10.1101/761551

Worms' Antimicrobial Peptides. 10.3390/md17090512

T(oo)bAd. 10.1038/s41589-019-0347-x

Theaflavins, polyphenols of black tea, inhibit entry of hepatitis C virus in cell culture. 10.1371/journal.pone.0198226

Plant extracts from Cameroonian medicinal plants strongly inhibit hepatitis C virus infection in vitro. 10.3389/fmicb.2015.00488

Discovery of Q203, a potent clinical candidate for the treatment of tuberculosis. 10.1038/nm.3262

Discovery of novel N-phenylphenoxyacetamide derivatives as EthR inhibitors and ethionamide boosters by combining high-throughput screening and synthesis. 10.1021/jm300377g

Shortening the drug discovery pipeline: small molecule high content screening for lead discovery in neglected disease. 10.1186/1753-6561-5-s1-p38

Automated HTS/HCS for antivirals using visual HIV full replication assays. 10.1186/1742-4690-6-s2-p82

Influence of ESAT-6 secretion system 1 (RD1) of Mycobacterium tuberculosis on the interaction between mycobacteria and the host immune system. 10.4049/jimmunol.174.6.3570

Cell microbiology interview 10.1111/cmi.13288

Pathogenomic analyses of Mycobacterium microti, an ESX-1-deleted member of the Mycobacterium tuberculosis complex causing disease in various hosts 10.1099/mgen.0.000505

PRABHAKAR KOTA

KOTA PRABHAKAR

ORCID: 0000-0002-7537-8433

Analysis of detection methods for space frequency block code MIMO-OFDM system in fast fading channels 10.15866/irecap.v7i7.13613

Analytical performance of OFDM transceiver on SDR and GNU radio-companion 10.1109/ICCSP.2017.8286471

Fireflies algorithm based optimal scrambling to reduce PAPR in SFBC based MIMO-OFDM 10.15866/irecap.v7i7.13567

Railroad track maintenance device 10.15866/irecap.v7i6.13605

A survey on evolution in information security 10.15866/irecap.v7i6.13347

BER analysis of PAPR reduction techniques in SFBC OFDM system: A review 10.1109/INFOP.2015.7489360

Chronic hyper-leptinemia induces insulin signaling disruption in adipocytes: Implications of NOS2 10.1016/j.freeradbiomed.2017.07.016

Fingerprint and iris biometric controlled smart banking machine embedded with GSM technology for OTP 10.1109/ICACDOT.2016.7877618

Ethyl acetate fraction of Eclipta alba: a potential phytopharmaceutical targeting adipocyte differentiation 10.1016/j.biopha.2017.10.002

Multistage recognition approach for handwritten devanagari script recognition 10.1109/WICT.2012.6409156

C-3 alkyl/arylalkyl-2,3-dideoxy hex-2-enopyranosides as antitubercular agents: Synthesis, biological evaluation, and QSAR study 10.1021/jm070110h

Throughput improvement of high density wireless personal area networks 10.1109/CICN.2014.116

Poliothrysoside and its derivatives as novel insulin sensitizers potentially driving AMPK activation and inhibiting adipogenesis 10.1016/j.ejmech.2014.09.015

Comparison of Different Signal Processing Techniques Used for Extraction of Breathing Frequency of Human Being Hidden Behind a Wall 10.1007/978-981-32-9515-5_1

A withanolide coagulin-L inhibits adipogenesis modulating Wnt/β-catenin pathway and cell cycle in mitotic clonal expansion 10.1016/j.phymed.2013.10.009

Identification and quantification of secondary metabolites of Pterocarpus marsupium by LC–MS techniques and its in-vitro lipid lowering activity 10.1016/j.indcrop.2018.10.047

Ecliptal, a promising natural lead isolated from Eclipta alba modulates adipocyte function and ameliorates metabolic syndrome 10.1016/j.taap.2017.11.016

Restoring thermorheological simplicity in miscible polymer blends: How many hydrogen bonds are required? 10.1021/ma100508c

INTRAVESICAL FEMORAL HEAD 10.1016/S0140-6736(76)92383-7

Facial features based hybrid methods for emotion recognition 10.35940/ijrte.B1065.0982S1019

Temporal immmunometabolic profiling of adipose tissue in HFD-induced obesity: manifestations of mast cells in fibrosis and senescence 10.1038/s41366-018-0228-5

PPP2R5B, a regulatory subunit of PP2A, contributes to adipocyte insulin resistance 10.1016/j.mce.2016.08.016

Review of unstructured architecture for voice and data services in mobile communication 10.1109/ICECCT.2015.7226190

Modeling and throughput analysis of randomly deployed IEEE 802.15.4 based Wireless Personal Area Networks 10.1109/PERVASIVE.2015.7086992

Search of antitubercular activities in tetrahydroacridines: Synthesis and biological evaluation 10.1016/j.bmcl.2006.07.025

A novel CPW-FED circular square-corner fractal antenna with varying notch-band for UWB applications 10.1109/ICCICT.2012.6398126

Preparation and reactions of sugar azides with alkynes: synthesis of sugar triazoles as antitubercular agents 10.1016/j.carres.2008.02.013

Synthesis and antitubercular activity of substituted phenylmethyl- and pyridylmethyl amines 10.1016/j.bmc.2006.09.020

Aegeline inspired synthesis of novel amino alcohol and thiazolidinedione hybrids with antiadipogenic activity in 3T3-L1 cells 10.1016/j.ejmech.2017.11.041

Lipid lowering oxopropanylindole hydrazone derivatives with antioxidant and anti-hyperglycemic activity 10.2174/1568026619666181220112903

Identification of novel PTP1B inhibitors by pharmacophore based virtual screening, scaffold hopping and docking 10.1194/jlr.M039925

Reduced Insulin Receptor Expression Enhances Proximal Tubule Gluconeogenesis 10.1002/jcb.25632

Design and synthesis of novel pyranone-based insulin sensitizers exhibiting in vivo hepatoprotective activity 10.1039/c3md00178d

Recent advancement in nitric oxide research in India 10.16943/ptinsa/2018/49300

Synthesis of galactopyranosyl amino alcohols as a new class of antitubercular and antifungal agents 10.1016/j.bmcl.2003.11.020

Synthesis and evaluation of antitubercular activity of glycosyl thio- and sulfonyl acetamide derivatives 10.1016/j.bmcl.2008.06.004

Artemisinin-derived stable ozonides: Synthesis and antitubercular activities 10.1007/s00044-006-1504-9

Novel indole and triazole based hybrid molecules exhibit potent anti-adipogenic and antidyslipidemic activity by activating Wnt3a/β-catenin pathway 10.1016/j.ejmech.2017.10.034

Effect of substituents on diarylmethanes for antitubercular activity 10.1016/j.ejmech.2006.09.020

Frame converter for cooperative coexistence between IEEE 802.15.4 Wireless Sensor Networks and Wi-Fi 10.1007/978-81-322-2529-4_16

A clerodane diterpene inhibit adipogenesis by cell cycle arrest and ameliorate obesity in C57BL/6 mice 10.1016/j.mce.2014.09.024

Mycobacterium tuberculosis persistence in various adipose depots of infected mice and the effect of anti-tubercular therapy 10.1016/j.micinf.2014.04.006

Chronic hyperinsulinemia reduces insulin sensitivity and metabolic functions of brown adipocyte 10.1530/JOE-16-0099

A facile synthesis of α,α′-(EE)-bis(benzylidene)-cycloalkanones and their antitubercular evaluations 10.1016/j.ejmech.2008.09.026

MiR-876-3p regulates glucose homeostasis and insulin sensitivity by targeting adiponectin 10.1530/JOE-17-0387

Throughput Improvement of Health Care Networks in Retirement Communities 10.1109/ICCTCT.2018.8551157

An approach to remove the clutter and detect the target for ultra-wideband through-wall imaging 10.1088/1742-2132/5/4/005

Extraction of life sign of human being hidden behind the wall 10.1109/ICIINFS.2016.8263071

Development of Unstructured Architecture for Voice and Data Services in Mobile Communication 10.1016/j.procs.2016.07.327

Limb girdle muscular dystrophy (LGMD): Case report 10.7860/JCDR/2015/10107.5486

Chronic hyperinsulinemia promotes meta-inflammation and extracellular matrix deposition in adipose tissue: Implications of nitric oxide 10.1016/j.mce.2018.05.010

Two calorimetric glass transitions in miscible blends containing poly(ethylene oxide) 10.1021/ma702429r

Non verbal approach for emotion detection 10.1007/978-3-319-31277-4_33

Statistical moments based facial expression analysis 10.1109/IADCC.2015.7154768

WPAN based preventive condition monitoring for solar wind energy converters in rural electrification 10.1109/CICN.2013.123

Neural network assisted effective lossy compression of medical images 10.1080/02564602.2006.11657937

Synthesis and antitubercular activities of bis-glycosylated diamino alcohols 10.1016/j.bmc.2005.05.021

Baylis-Hillman reaction: Convenient ascending syntheses and biological evaluation of acyclic deoxy monosaccharides as potential antimycobacterial agents 10.1016/S0968-0896(02)00210-9

Analysis of clutter reduction techniques for through wall imaging in UWB range 10.2528/PIERB09060903

Immunogenic membrane-associated proteins of Mycobacterium tuberculosis revealed by proteomics 10.1099/mic.0.27799-0

Saroglitazar reduces obesity and associated inflammatory consequences in murine adipose tissue 10.1016/j.ejphar.2018.01.002

Bile acid receptor agonist GW4064 regulates PPARγ coactivator-1α expression through estrogen receptor-related receptor α 10.1210/me.2010-0512

A self banking biometric machine with fake detection applied to fingerprint and iris along with GSM technology for OTP 10.1109/ICCSP.2016.7754189

Design, synthesis and antitubercular activity of diarylmethylnaphthol derivatives 10.1016/j.bmcl.2007.07.089

Stable Tricyclic Antitubercular Ozonides Derived from Artemisinin 10.1021/acs.orglett.5b02296

Synthesis and antimycobacterial activities of glycosylated amino alcohols and amines 10.1016/j.ejmech.2004.12.002

An iris recognition based on dual tree complex wavelet transform 10.1109/TENCON.2007.4429050

Aegeline inspired synthesis of novel β3-AR agonist improves insulin sensitivity in vitro and in vivo models of insulin resistance 10.1016/j.metabol.2018.03.001

Improvement in detection of human life sign signal hidden behind the wall using clutter reduction technique 10.1109/ETCT.2016.7882972

An automated segmentation method for iris recognition 10.1109/TENCON.2006.344211

Biometric person identification—methods, advances and performance evaluation 10.1080/02564602.2004.11417147

Investigation of Transmission line modelling method for dielectric characterization using ring resonator 10.1109/AEMC.2015.7509157

Role of brown adipose tissue in modulating adipose tissue inflammation and insulin resistance in high-fat diet fed mice 10.1016/j.ejphar.2019.02.044

Adipocyte transdifferentiation and its molecular targets 10.1016/j.diff.2014.07.002

RF and microwave low power dielectric heating using parallel plate applicator to control insect pests on tomato plant 10.2528/PIERM16051806

Recognition of target in through wall imaging using shape feature extraction 10.1109/IGARSS.2011.6049291

Boxed ring resonator for liquid dielectric constant measurement 10.15866/irecap.v8i6.15170

Curcumin-3,4-Dichloro Phenyl Pyrazole (CDPP) overcomes curcumin's low bioavailability, inhibits adipogenesis and ameliorates dyslipidemia by activating reverse cholesterol transport 10.1016/j.metabol.2017.05.005

Determinants of natural immunity against tuberculosis in an endemic setting: Factors operating at the level of macrophage-Mycobacterium tuberculosis interaction 10.1111/j.1365-2249.2007.03585.x

Corrigendum to “Chronic hyper-leptinemia induces insulin signaling disruption in adipocytes: Implications of NOS2.” [Free Radical Biology and Medicine 112 (2017) 93–108](S0891584917306998)(10.1016/j.freeradbiomed.2017.07.016) 10.1016/j.freeradbiomed.2018.05.072

16-Dehydropregnenolone lowers serum cholesterol by up-regulation of CYP7A1 in hyperlipidemic male hamsters 10.1016/j.jsbmb.2017.02.013

Synthesis and antitubercular screening of imidazole derivatives 10.1016/j.ejmech.2009.02.013

Experimental study and analysis of stepped-frequency continuous wave based radar for through the wall detection of life signs 10.1109/TENCON.2016.7848280

Dielectric constant measurement of low loss liquids using stacked multi ring resonator 10.1007/s12046-018-0973-0

Chronic hyperinsulinemia induced miR-27b is linked to adipocyte insulin resistance by targeting insulin receptor 10.1007/s00109-018-1623-z

Simulation modeling and implementation of RF and MW system to control the insect pests in agriculture 10.1109/INDICON.2015.7443504

Application of clutter reduction techniques for detection of metallic and low dielectric target behind the brick wall by stepped frequency continuous wave radar in ultra-wideband range 10.1049/iet-rsn.2010.0059

Pharmacokinetic and metabolism studies of rohitukine in rats by high performance liquid-chromatography with tandem mass spectrometry 10.1016/j.fitote.2014.05.004

Pawan Sharma

Sharma Pawan

ORCID: 0000-0002-2525-5451

Evaluation of anti-leishmanial activity of selected Indian plants known to have antimicrobial properties 10.1007/s00436-009-1554-2

Antibody responses stimulated in rabbits, guinea-pigs and mice by recombinant and synthetic portions of a 75 kDa malarial merozoite protein 10.1016/0264-410X(92)90354-M

Activity of Trifluoperazine against Replicating, Non-Replicating and Drug Resistant M. tuberculosis 10.1371/journal.pone.0044245

Intracellular expression of Mycobacterium tuberculosis-specific 10-kDa antigen down-regulates macrophage B7·1 expression and nitric oxide release 10.1046/j.1365-2249.2003.02258.x

Molecular modelling and comparative structural account of aspartyl β-semialdehyde dehydrogenase of Mycobacterium tuberculosis (H37Rv) 10.1007/s00894-008-0267-2

Early secreted antigen ESAT-6 of mycobacterium tuberculosis promotes protective T helper 17 cell responses in a toll-like receptor-2-dependent manner 10.1371/journal.ppat.1002378

Immunomodulatory action of mycobacterial secretory proteins 10.1016/j.micinf.2003.12.015

Immunogenicity of candidate chimeric DNA vaccine against tuberculosis and leishmaniasis 10.1016/j.vaccine.2009.05.100

Kinesin motor domain of Leishmania donovani as a future vaccine candidate 10.1128/CVI.00433-07

Improved diagnosis of tuberculosis in HIV-positive patients using RD1-encoded antigen CFP-10 10.1016/j.ijid.2008.09.022

Mycobacterium tuberculosis secretory proteins CFP-10, ESAT-6 and the CFP10:ESAT6 complex inhibit lipopolysaccharide-induced NF-κB transactivation by downregulation of reactive oxidative species (ROS) production 10.1038/sj.icb.7100117

Supplementation with RD antigens enhances the protective efficacy of BCG in tuberculous mice 10.1016/j.clim.2007.07.007

Mycobacterium tuberculosis TlyA protein negatively regulates T helper (Th) 1 and Th17 differentiation and promotes tuberculosis pathogenesis 10.1074/jbc.M115.653600

Down-regulation of T helper 1 responses to mycobacterial antigens due to maturation of dendritic cells by 10-kDa Mycobacterium tuberculosis secretory antigen 10.1086/368173

Regulation of immune responses to Mycobacterium tuberculosis secretory antigens by dendritic cells 10.1016/j.tube.2005.08.007

ESAT-6 induced COX-2 expression involves coordinated interplay between PI3K and MAPK signaling 10.1016/j.molimm.2011.11.011

A multivalent combination of experimental antituberculosis DNA vaccines based on Ag85B and regions of difference antigens 10.1016/j.micinf.2006.04.025

Encapsulation of antigenic secretory proteins of mycobacterium tuberculosis in biopolymeric nanoparticles for possible aerosol delivery system 10.1166/jbns.2011.1042

Mycobacterium tuberculosis evades host immunity by recruiting mesenchymal stem cells 10.1073/pnas.1007967107

Expression and characterization of a recombinant kinesin antigen from an old Indian strain (DD8) of Leishmania donovani and comparing it with a commercially available antigen from a newly isolated (KE16) strain of L. donovani 10.1016/j.meegid.2008.02.004

Immunogenic membrane-associated proteins of Mycobacterium tuberculosis revealed by proteomics 10.1099/mic.0.27799-0

Identification of a novel role of ESAT-6-dependent miR-155 induction during infection of macrophages with mycobacterium tuberculosis 10.1111/j.1462-5822.2012.01827.x

Cloning, expression, and purification of a novel recombinant antigen from Leishmania donovani 10.1016/j.pep.2005.07.027

Mycobacterium tuberculosis 6 kDa early secreted antigenic target stimulates activation of J774 macrophages 10.1016/j.imlet.2004.11.011

T cells from programmed death-1 deficient mice respond poorly to mycobacterium tuberculosis infection 10.1371/journal.pone.0019864

Pathogen-Specific Treg Cells Expand Early during Mycobacterium tuberculosis Infection but Are Later Eliminated in Response to Interleukin-12 10.1016/j.immuni.2013.06.003

Merozoite surface antigen 2 (MSA-2) gene of Plasmodium falciparum strains from India 10.1016/0166-6851(96)83010-6

Evaluation of the diagnostic potential of region of deletion-1-encoded antigen culture filtrate protein-10 in pulmonary tuberculosis 10.1016/j.diagmicrobio.2007.05.011

Mycobacterium tuberculosis 6-kDa early secreted antigenic target (ESAT-6) protein downregulates Lipopolysaccharide induced c-myc expression by modulating the extracellular signal regulated kinases 1/2 10.1186/1471-2172-8-24

ESAT6 differentially inhibits IFN-γ-inducible class II transactivator isoforms in both a TLR2-dependent and -independent manner 10.1038/icb.2011.54

Co-dominant and reciprocal T-helper cell activity of epitopic sequences and formation of junctional B-cell determinants in synthetic T:B chimeric immunogens 10.1016/0264-410X(93)90102-4

Cross-regulation of CD86 by CD80 differentially regulates T helper responses from Mycobacterium tuberculosis secretory antigen-activated dendritic cell subsets 10.1189/jlb.1003476

Emergence and molecular characterization of extensively drug-resistant Mycobacterium tuberculosis clinical isolates from the Delhi region in India 10.1128/AAC.00661-10

Effect of Mycobacterium tuberculosis-specific 10-kilodalton antigen on macrophage release of tumor necrosis factor alpha and nitric oxide 10.1128/IAI.70.12.6558-6566.2002

The PPE18 of Mycobacterium tuberculosis interacts with TLR2 and activates IL-10 induction in macrophage 10.4049/jimmunol.0901367

Immune responses mediating survival of naive BALB/c mice experimentally infected with lethal rodent malaria parasite, Plasmodium yoelii nigeriensis 10.1016/S1286-4579(00)00321-X

Innate immune responses to M. tuberculosis infection 10.1016/j.tube.2011.04.003

Molecular typing of neisseria gonorrhoeae isolates by opa-typing and ribotyping in New Delhi, India 10.1155/2009/934823

Fine specificity of immune responses to epitopic sequences in synthetic peptides containing B and T epitopes from the conserved Plasmodium falciparum blood-stage antigens 10.1016/0264-410X(94)00052-O

Mycobacterium tuberculosis secreted antigen (MTSA-10) modulates macrophage function by redox regulation of phosphatases 10.1111/j.1742-4658.2006.05543.x

Role of M. tuberculosis RD-1 region encoded secretory proteins in protective response and virulence 10.1016/j.tube.2008.05.002

Role of PPE18 Protein in Intracellular Survival and Pathogenicity of Mycobacterium tuberculosis in Mice 10.1371/journal.pone.0052601

Cloning and characterization of aspartate-β-semialdehyde dehydrogenase from Mycobacterium tuberculosis H37 Rv 10.1111/j.1365-2672.2004.02505.x

Expression and purification of the Mycobacterium tuberculosis complex-restricted antigen CFP21 to study its immunoprophylactic potential in mouse model 10.1016/j.pep.2006.03.010

Evaluation of 5 Novel protein biomarkers for the rapid diagnosis of pulmonary and extra-pulmonary tuberculosis: preliminary results 10.1038/srep44121

IL-10 down-regulates the expression of survival associated gene hspX of Mycobacterium tuberculosis in murine macrophage 10.1016/j.bjid.2017.03.009

Comparative proteomic analysis of sequential isolates of Mycobacterium tuberculosis sensitive and resistant Beijing type from a patient with pulmonary tuberculosis 10.1016/j.ijmyco.2016.10.028

ESAT6 differentially inhibits IFN-γ-inducible class II transactivator isoforms in both a TLR2-dependent and -independent manner. icb201154 [pii] 10.1038/icb.2011.54

Immuno-potentiating role of encapsulated proteins of infectious diseases in biopolymeric nanoparticles as a potential delivery system 10.1166/jbn.2011.1202

Innate immune responses to M. tuberculosis infection. S1472-9792(11)00066-7 [pii] 10.1016/j.tube.2011.04.003

T cells from Programmed Death-1 deficient mice respond poorly to Mycobacterium tuberculosis infection. PONE-D-11-02781 [pii] 10.1371/journal.pone.0019864

Emergence and molecular characterization of extensively drug-resistant Mycobacterium tuberculosis clinical isolates from the Delhi Region in India. AAC.00661-10 [pii] 10.1128/AAC.00661-10

Mycobacterium tuberculosis evades host immunity by recruiting mesenchymal stem cells. 1007967107 [pii] 10.1073/pnas.1007967107

Immunogenicity of candidate chimeric DNA vaccine against tuberculosis and leishmaniasis. S0264-410X(09)00837-8 [pii] 10.1016/j.vaccine.2009.05.100

Improved diagnosis of tuberculosis in HIV-positive patients using RD1-encoded antigen CFP-10. S1201-9712(08)01689-5 [pii] 10.1016/j.ijid.2008.09.022

The PPE18 of Mycobacterium tuberculosis interacts with TLR2 and activates IL-10 induction in macrophage. jimmunol.0901367 [pii] 10.4049/jimmunol.0901367

Kinesin motor domain of Leishmania donovani as a future vaccine candidate. CVI.00433-07 [pii] 10.1128/CVI.00433-07

Mycobacterium tuberculosis secretory proteins CFP-10, ESAT-6 and the CFP10:ESAT6 complex inhibit lipopolysaccharide-induced NF-kappaB transactivation by downregulation of reactive oxidative species (ROS) production. 7100117 [pii] 10.1038/sj.icb.7100117

Role of M. tuberculosis RD-1 region encoded secretory proteins in protective response and virulence. S1472-9792(08)00055-3 [pii] 10.1016/j.tube.2008.05.002

Evaluation of the diagnostic potential of region of deletion-1-encoded antigen culture filtrate protein-10 in pulmonary tuberculosis. S0732-8893(07)00234-9 [pii] 10.1016/j.diagmicrobio.2007.05.011

Mycobacterium tuberculosis 6-kDa early secreted antigenic target (ESAT-6) protein downregulates lipopolysaccharide induced c-myc expression by modulating the extracellular signal regulated kinases 1/2. 1471-2172-8-24 [pii] 10.1186/1471-2172-8-24

Supplementation with RD antigens enhances the protective efficacy of BCG in tuberculous mice. S1521-6616(07)01286-7 [pii] 10.1016/j.clim.2007.07.007

A multivalent combination of experimental antituberculosis DNA vaccines based on Ag85B and regions of difference antigens. S1286-4579(06)00235-8 [pii] 10.1016/j.micinf.2006.04.025

Cloning, expression, and purification of a novel recombinant antigen from Leishmania donovani. S1046-5928(05)00261-5 [pii] 10.1016/j.pep.2005.07.027

Expression and purification of the Mycobacterium tuberculosis complex-restricted antigen CFP21 to study its immunoprophylactic potential in mouse model. S1046-5928(06)00094-5 [pii] 10.1016/j.pep.2006.03.010

Mycobacterium tuberculosis secreted antigen (MTSA-10) modulates macrophage function by redox regulation of phosphatases. EJB5543 [pii] 10.1111/j.1742-4658.2006.05543.x

Cloning and characterization of aspartate-beta-semialdehyde dehydrogenase from Mycobacterium tuberculosis H37 Rv. JAM2505 [pii] 10.1111/j.1365-2672.2004.02505.x

Immunogenic membrane-associated proteins of Mycobacterium tuberculosis revealed by proteomics. 151/7/2411 [pii] 10.1099/mic.0.27799-0

Mycobacterium tuberculosis 6 kDa early secreted antigenic target stimulates activation of J774 macrophages. S0165-2478(04)00316-5 [pii] 10.1016/j.imlet.2004.11.011

Regulation of immune responses to Mycobacterium tuberculosis secretory antigens by dendritic cells. S1472-9792(05)00068-5 [pii] 10.1016/j.tube.2005.08.007

Cross-regulation of CD86 by CD80 differentially regulates T helper responses from Mycobacterium tuberculosis secretory antigen-activated dendritic cell subsets. jlb.1003476 [pii] 10.1189/jlb.1003476

Immunomodulatory action of mycobacterial secretory proteins. S1286457904000395 [pii] 10.1016/j.micinf.2003.12.015

Down-regulation of T helper 1 responses to mycobacterial antigens due to maturation of dendritic cells by 10-kDa mycobacterium tuberculosis secretory antigen. JID21064 [pii] 10.1086/368173

Intracellular expression of Mycobacterium tuberculosis-specific 10-kDa antigen down-regulates macrophage B7.1 expression and nitric oxide release. 2258 [pii]

Mycobacterium tuberculosis antigens induce the differentiation of dendritic cells from bone marrow. 10.4049/jimmunol.169.12.6856

Immune responses mediating survival of naive BALB/c mice experimentally infected with lethal rodent malaria parasite, Plasmodium yoelii nigeriensis. S1286-4579(00)00321-X [pii]

Fine specificity of immune responses to epitopic sequences in synthetic peptides containing B and T epitopes from the conserved Plasmodium falciparum blood-stage antigens. 0264410X9400052O [pii]

Merozoite surface antigen 2 (MSA-2) gene of Plasmodium falciparum strains from India. 0166685196830106 [pii]

Co-dominant and reciprocal T-helper cell activity of epitopic sequences and formation of junctional B-cell determinants in synthetic T:B chimeric immunogens. 0264-410X(93)90102-4 [pii]

Immunogenicity and efficacy trials in Aotus nancymai monkeys with model compounds representing parts of a 75-kD merozoite surface antigen of Plasmodium falciparum. 10.4269/ajtmh.1992.46.691

Nathalie deboosere

deboosere Nathalie

ORCID: 0000-0002-2873-5485

ArfGAP1 restricts Mycobacterium tuberculosis entry by controlling the actin cytoskeleton. 10.15252/embr.201744371

Mycobacterium tuberculosis Controls Phagosomal Acidification by Targeting CISH-Mediated Signaling. 10.1016/j.celrep.2017.08.101

A Bacterial Toxin with Analgesic Properties: Hyperpolarization of DRG Neurons by Mycolactone. 10.3390/toxins9070227

Phenotypic assays for Mycobacterium tuberculosis infection. 10.1002/cyto.a.23129

Fragment-Sized EthR Inhibitors Exhibit Exceptionally Strong Ethionamide Boosting Effect in Whole-Cell Mycobacterium tuberculosis Assays. 10.1021/acschembio.7b00091

STAT3 Represses Nitric Oxide Synthesis in Human Macrophages upon Mycobacterium tuberculosis Infection. 10.1038/srep29297

LppM impact on the colonization of macrophages by Mycobacterium tuberculosis. 10.1111/cmi.12619

A microscopic phenotypic assay for the quantification of intracellular mycobacteria adapted for high-throughput/high-content screening. 10.3791/51114

Adhesion of human pathogenic enteric viruses and surrogate viruses to inert and vegetal food surfaces. 10.1016/j.fm.2012.04.007

Viral elution and concentration method for detection of influenza A viruses in mud by real-time RT-PCR. 10.1016/j.jviromet.2011.10.013

Comparison of chlorine and peroxyacetic-based disinfectant to inactivate Feline calicivirus, Murine norovirus and Hepatitis A virus on lettuce. 10.1016/j.ijfoodmicro.2011.08.011

Direct detection of highly pathogenic avian influenza A/H5N1 virus from mud specimens. 10.1016/j.jviromet.2011.06.002

Development and validation of a concentration method for the detection of influenza a viruses from large volumes of surface water. 10.1128/aem.02484-10

A predictive microbiology approach for thermal inactivation of Hepatitis A virus in acidified berries. 10.1016/j.fm.2010.05.018

Assessment of the removal and inactivation of influenza viruses H5N1 and H1N1 by drinking water treatment. 10.1016/j.watres.2010.01.013

Intra-laboratory validation of a concentration method adapted for the enumeration of infectious F-specific RNA coliphage, enterovirus, and hepatitis A virus from inoculated leaves of salad vegetables. 10.1016/j.ijfoodmicro.2005.11.007

Modelling effect of physical and chemical parameters on heat inactivation kinetics of hepatitis A virus in a fruit model system. 10.1016/j.ijfoodmicro.2003.10.015

Host-pathogen systems for early drug discovery against tuberculosis. 10.1016/j.mib.2017.11.017

Mycobacterium tuberculosis inhibits human innate immune responses via the production of TLR2 antagonist glycolipids. 10.1073/pnas.1707840114

Cyclipostins and Cyclophostin analogs as promising compounds in the fight against tuberculosis. 10.1038/s41598-017-11843-4

Legionella pneumophila Modulates Mitochondrial Dynamics to Trigger Metabolic Repurposing of Infected Macrophages. 10.1016/j.chom.2017.07.020

Combination therapy for tuberculosis treatment: pulmonary administration of ethionamide and booster co-loaded nanoparticles. 10.1038/s41598-017-05453-3

Host-directed therapies offer novel opportunities for the fight against tuberculosis. 10.1016/j.drudis.2017.05.005

Cyclodextrin-based nanocarriers containing a synergic drug combination: A potential formulation for pulmonary administration of antitubercular drugs. 10.1016/j.ijpharm.2017.05.030

Impact of pe_pgrs33 Gene Polymorphisms on Mycobacterium tuberculosis Infection and Pathogenesis. 10.3389/fcimb.2017.00137

Clofazimine encapsulation in nanoporous silica particles for the oral treatment of antibiotic-resistant Mycobacterium tuberculosis infections. 10.2217/nnm-2016-0364

Reversion of antibiotic resistance in Mycobacterium tuberculosis by spiroisoxazoline SMARt-420. 10.1126/science.aag1006

How can nanoparticles contribute to antituberculosis therapy? 10.1016/j.drudis.2017.01.011

Genome-wide, high-content siRNA screening identifies the Alzheimer's genetic risk factor FERMT2 as a major modulator of APP metabolism. 10.1007/s00401-016-1652-z

Identification of aminopyrimidine-sulfonamides as potent modulators of Wag31-mediated cell elongation in mycobacteria. 10.1111/mmi.13535

Mycobacterium tuberculosis LppM Displays an Original Structure and Domain Composition Linked to a Dual Localization. 10.1016/j.str.2016.07.009

Khaya grandifoliola C.DC: a potential source of active ingredients against hepatitis C virus in vitro. 10.1007/s00705-016-2771-5

[Mycolactone: the amazing analgesic mycobacterial toxin]. 10.1051/medsci/20163202007

A fragment merging approach towards the development of small molecule inhibitors of Mycobacterium tuberculosis EthR for use as ethionamide boosters. 10.1039/c5ob02630j

Polyphenols Inhibit Hepatitis C Virus Entry by a New Mechanism of Action. 10.1128/jvi.01473-15

Plant extracts from Cameroonian medicinal plants strongly inhibit hepatitis C virus infection in vitro. 10.3389/fmicb.2015.00488

Increased protective efficacy of recombinant BCG strains expressing virulence-neutral proteins of the ESX-1 secretion system. 10.1016/j.vaccine.2015.03.083

Cytosolic access of Mycobacterium tuberculosis: critical impact of phagosomal acidification control and demonstration of occurrence in vivo. 10.1371/journal.ppat.1004650

[High content screening in chemical biology: overview and main challenges]. 10.1051/medsci/20153102016

Testing chemical and genetic Modulators in Mycobacterium tuberculosis infected cells using phenotypic assays. 10.1007/978-1-4939-2450-9_24

2-Carboxyquinoxalines kill mycobacterium tuberculosis through noncovalent inhibition of DprE1. 10.1021/cb5007163

High-content screening technology combined with a human granuloma model as a new approach to evaluate the activities of drugs against Mycobacterium tuberculosis. 10.1128/aac.03705-14

Mycobacterial toxin induces analgesia in buruli ulcer by targeting the angiotensin pathways. 10.1016/j.cell.2014.04.040

Ligand efficiency driven design of new inhibitors of Mycobacterium tuberculosis transcriptional repressor EthR using fragment growing, merging, and linking approaches. 10.1021/jm500422b

Discovery of Q203, a potent clinical candidate for the treatment of tuberculosis. 10.1038/nm.3262

The balance of apoptotic and necrotic cell death in Mycobacterium tuberculosis infected macrophages is not dependent on bacterial virulence. 10.1371/journal.pone.0047573

Discovery of novel N-phenylphenoxyacetamide derivatives as EthR inhibitors and ethionamide boosters by combining high-throughput screening and synthesis. 10.1021/jm300377g

Ethionamide boosters. 2. Combining bioisosteric replacement and structure-based drug design to solve pharmacokinetic issues in a series of potent 1,2,4-oxadiazole EthR inhibitors. 10.1021/jm200825u

A novel specific edge effect correction method for RNA interference screenings. 10.1093/bioinformatics/btr648

Analogous mechanisms of resistance to benzothiazinones and dinitrobenzamides in Mycobacterium smegmatis. 10.1371/journal.pone.0026675

High-content screening in infectious diseases. 10.1016/j.cbpa.2011.05.023

Ethionamide boosters: synthesis, biological activity, and structure-activity relationships of a series of 1,2,4-oxadiazole EthR inhibitors. 10.1021/jm200076a

Shortening the drug discovery pipeline: small molecule high content screening for lead discovery in neglected disease. 10.1186/1753-6561-5-s1-p38

High content phenotypic cell-based visual screen identifies Mycobacterium tuberculosis acyltrehalose-containing glycolipids involved in phagosome remodeling. 10.1371/journal.ppat.1001100

High-content imaging of Mycobacterium tuberculosis-infected macrophages: an in vitro model for tuberculosis drug discovery. 10.4155/fmc.10.223

Functional characterization of the Mycobacterium tuberculosis serine/threonine kinase PknJ. 10.1099/mic.0.038133-0

High content screening identifies decaprenyl-phosphoribose 2' epimerase as a target for intracellular antimycobacterial inhibitors. 10.1371/journal.ppat.1000645

Systematic genetic nomenclature for type VII secretion systems. 10.1371/journal.ppat.1000507

Long-circulating DNA lipid nanocapsules as new vector for passive tumor targeting. 10.1016/j.biomaterials.2009.09.044

Automated HTS/HCS for antivirals using visual HIV full replication assays. 10.1186/1742-4690-6-s2-p82

Benzothiazinones kill Mycobacterium tuberculosis by blocking arabinan synthesis. 10.1126/science.1171583

Automated high-throughput siRNA transfection in raw 264.7 macrophages: a case study for optimization procedure. 10.1177/1087057108328762

Control of M. tuberculosis ESAT-6 secretion and specific T cell recognition by PhoP. 10.1371/journal.ppat.0040033

ESAT-6 from Mycobacterium tuberculosis dissociates from its putative chaperone CFP-10 under acidic conditions and exhibits membrane-lysing activity. 10.1128/jb.00469-07

[Aquatic insects and transmission of Mycobacterium ulcerans]. 10.1051/medsci/20072367572

Impact of Mycobacterium ulcerans biofilm on transmissibility to ecological niches and Buruli ulcer pathogenesis. 10.1371/journal.ppat.0030062

Protection against Mycobacterium ulcerans lesion development by exposure to aquatic insect saliva. 10.1371/journal.pmed.0040064

Synthesis and antimycobacterial evaluation of benzofurobenzopyran analogues. 10.1016/j.bmc.2006.12.009

Inactivation of Rv2525c, a substrate of the twin arginine translocation (Tat) system of Mycobacterium tuberculosis, increases beta-lactam susceptibility and virulence. 10.1128/jb.00631-06

High frequency of CD4+ T cells specific for the TB10.4 protein correlates with protection against Mycobacterium tuberculosis infection. 10.1128/iai.02086-05

Benzofuro[3,2-f][1]benzopyrans: a new class of antitubercular agents. 10.1016/j.bmc.2006.03.033

An increase in antimycobacterial Th1-cell responses by prime-boost protocols of immunization does not enhance protection against tuberculosis. 10.1128/iai.74.4.2128-2137.2006

Dissection of ESAT-6 system 1 of Mycobacterium tuberculosis and impact on immunogenicity and virulence. 10.1128/iai.74.1.88-98.2006

Tuberculosis: from genome to vaccine. 10.1586/14760584.4.4.541

Immunogenic membrane-associated proteins of Mycobacterium tuberculosis revealed by proteomics. 10.1099/mic.0.27799-0

Influence of ESAT-6 secretion system 1 (RD1) of Mycobacterium tuberculosis on the interaction between mycobacteria and the host immune system. 10.4049/jimmunol.174.6.3570

Evaluation of vaccines in the EU TB Vaccine Cluster using a guinea pig aerosol infection model of tuberculosis. 10.1016/j.tube.2004.09.009

ESAT-6 proteins: protective antigens and virulence factors? 10.1016/j.tim.2004.09.007

Enhanced protection against tuberculosis by vaccination with recombinant Mycobacterium microti vaccine that induces T cell immunity against region of difference 1 antigens. 10.1086/421468

Cell envelope protein PPE68 contributes to Mycobacterium tuberculosis RD1 immunogenicity independently of a 10-kilodalton culture filtrate protein and ESAT-6. 10.1128/iai.72.4.2170-2176.2004

CD8+-T-cell responses of Mycobacterium-infected mice to a newly identified major histocompatibility complex class I-restricted epitope shared by proteins of the ESAT-6 family. 10.1128/iai.71.12.7173-7177.2003

Recombinant BCG exporting ESAT-6 confers enhanced protection against tuberculosis. 10.1038/nm859

Loss of RD1 contributed to the attenuation of the live tuberculosis vaccines Mycobacterium bovis BCG and Mycobacterium microti. 10.1046/j.1365-2958.2002.03237.x

Bacterial artificial chromosome-based comparative genomic analysis identifies Mycobacterium microti as a natural ESAT-6 deletion mutant. 10.1128/iai.70.10.5568-5578.2002

Disruption of HIV-1 integrase-DNA complexes by short 6-oxocytosine-containing oligonucleotides. 10.1021/bi015732y

IRG1 controls immunometabolic host response and restricts intracellular Mycobacterium tuberculosis infection 10.1101/761551

Large scale screening discovers clofoctol as an inhibitor of SARS-CoV-2 replication that reduces COVID-19-like pathology 10.1101/2021.06.30.450483

abdelkader Namane

Namane abdelkader

ORCID: 0000-0001-7180-7619

A minimal bacterial RNase J-based degradosome is associated with translating ribosomes 10.1093/nar/gks945

New Markers in Anopheles gambiae Salivary Glands After Plasmodium berghei Infection 10.1089/vbz.2012.0964

Yeast ribosomal protein L7 and its homologue Rlp7 are simultaneously present at distinct sites on pre-60S ribosomal particles 10.1093/nar/gkt726

Identification of Outer Membrane Proteins Altered in Response to UVC-Radiation in Vibrio parahaemolyticus and Vibrio alginolyticus 10.1007/s12088-012-0299-2

A Critical Role of Perinuclear Filamentous Actin in Spatial Repositioning and Mutually Exclusive Expression of Virulence Genes in Malaria Parasites 10.1016/j.chom.2011.09.013

Characterization of the Antibody Response to the Saliva of Phlebotomus papatasi in People Living in Endemic Areas of Cutaneous Leishmaniasis 10.4269/ajtmh.2011.10-0598

AIF promotes chromatinolysis and caspase-independent programmed necrosis by interacting with histone H2AX 10.1038/emboj.2010.43

CCSV-MPase, a Novel Procoagulant Metalloproteinase from Cerastes cerastes Venom: Purification, Biochemical Characterization and Protein Identification 10.1007/s10930-010-9273-1

Identification of Leishmania-specific protein phosphorylation sites by LC-ESI-MS/MS and comparative genomics analyses 10.1002/pmic.201000305

Identification of outer membrane proteins of Vibrio parahaemolyticus and Vibrio alginolyticus altered in response to gamma-irradiation or long-term starvation 10.1016/j.resmic.2010.10.009

Phosphoproteome dynamics reveal heat-shock protein complexes specific to the Leishmania donovani infectious stage 10.1073/pnas.0914768107

IgG Autoantibody to Brain Beta Tubulin III Associated with Cytokine Cluster-II Discriminate Cerebral Malaria in Central India 10.1371/journal.pone.0008245

60S ribosomal subunit assembly dynamics defined by semi-quantitative mass spectrometry of purified complexes 10.1093/nar/gkn469

Comprehensive proteome analysis of Mycobacterium ulcerans and quantitative comparison of mycolactone biosynthesis 10.1002/pmic.200701018

In Vivo Interactome of Helicobacter pylori Urease Revealed by Tandem Affinity Purification 10.1074/mcp.M800160-MCP200

Phosphoproteornic analysis of Leishmania donovani pro- and amastigote stages 10.1002/pmic.200700697

A critical role for peptidoglycan N-deacetylation in Listeria evasion from the host innate immune system 10.1073/pnas.0609672104

Self-Reactivities to the Non-Erythroid Alpha Spectrin Correlate with Cerebral Malaria in Gabonese Children 10.1371/journal.pone.0000389

The HcaR regulatory protein of Photorhabdus luminescens affects the production of proteins involved in oxidative stress and toxemia 10.1002/pmic.200700609

The p21-activated protein kinase inhibitor Skb15 and its budding yeast homologue are 60S ribosome assembly factors 10.1128/MCB.00064-07

The Pseudomonas aeruginosa LasB metalloproteinase regulates the human urokinase-type plasminogen activator receptor through domain-specific endoproteolysis 10.1128/IAI.00015-07

The salivary glands and saliva of Anopheles gambiae as an essential step in the Plasmodium life cycle: A global proteomic study 10.1002/pmic.200700334

Yeast homolog of a cancer-testis antigen defines a new transcription complex 10.1038/sj.emboj.7601235

Cryptic Pol II transcripts are degraded by a nuclear quality control pathway involving a new poly(A) polymerase 10.1016/j.cell.2005.04.030

Deletion of EFL1 results in heterogeneity of the 60 S GTPase-associated rRNA conformation 10.1016/j.jmb.2005.07.037

Immunogenic membrane-associated proteins of Mycobacterium tuberculosis revealed by proteomics 10.1099/mic.0.27799-0

LANCL1, an erythrocyte protein recruited to the Maurer's clefts during Plasmodium falciparum development 10.1016/j.molbiopara.2005.01.013

Limited efficiency of prolyl-endopeptidase in the detoxification of gliadin peptides in celiac disease 10.1053/j.gastro.2005.06.016

Sequential neural network combination for degraded machine printed character recognition 10.1117/12.587162

Staphylococcus aureus RNAIII and the endoribonuclease III coordinately regulate spa gene expression 10.1038/sj.emboj.7600572

AstR-AstS, a new two-component signal transduction system, mediates swarming, adaptation to stationary phase and phenotypic variation in Photorhabdus luminescens 10.1099/mic.0.26563-0

Global analysis of gene expression in an rpoN mutant of Listeria monocytogenes 10.1099/mic.0.26860-0

Plasmin cleaves the juxtamembrane domain and releases truncated species of the urokinase receptor (CD87) from human bronchial epithelial cells 10.1016/j.febslet.2004.08.009

Alterations of the intestinal transport and processing of gliadin peptides in celiac disease 10.1016/S0016-5085(03)01049-7

Correlation between alterations of the penicillin-binding protein 2 and modifications of the peptidoglycan structure in Neisseria meningitidis with reduced susceptibility to penicillin G 10.1074/jbc.M304607200

Detailed structural analysis of the peptidoglycan of the human pathogen Neisseria meningitidis 10.1074/jbc.M304749200

Sequential protein association with nascent 60S ribosomal particles 10.1128/MCB.23.13.4449-4460.2003

A proteomic analysis of the salt stress response of Listeria monocytogenes 10.1016/S0378-1097(02)00938-2

A proteomic study of Escherichia coli O157 : H7 NCTC 12900 cultivated in biofilm or in planktonic growth mode 10.1016/S0378-1097(02)00879-0

Comparison of protein patterns of Listeria monocytogenes grown in biofilm or in planktonic mode by proteomic analysis 10.1016/S0378-1097(02)00571-2

Proteome analysis of the plasma membrane of Mycobacterium tuberculosis 10.1002/cfg.211

Structural and nucleotide-binding properties of YajQ and YnaF, two Escherichia coli proteins of unknown function 10.1110/ps.0217502

A yeast homolog of chromatin assembly factor 1 is involved in early ribosome assembly 10.1016/S0960-9822(01)00584-X

Identification of 12 new yeast mitochondrial ribosomal proteins including 6 that have no prokaryotic homologues 10.1074/jbc.M010864200

Nog2p, a putative GTPase associated with pre-60S subunits and required for late 60S maturation steps 10.1093/emboj/20.22.6475

Nonspecific B and T cell-stimulatory activity mediated by mast cells is associated with exosomes 10.1159/000053691

Genetic and biochemical characterization of Salmonella enterica serovar Typhi deoxyribokinase 10.1128/JB.182.4.869-873.2000

Assay of nucleoside 2-deoxyribosyltransferase activity with pyruvate kinase lactate dehydrogenase coupling system 10.1006/abio.1999.4136

Decreased capacity of recombinant 45/47-kDa molecules (Apa) of Mycobacterium tuberculosis to stimulate T lymphocyte responses related to changes in their mannosylation pattern 10.1074/jbc.274.45.32023

Unusual nucleotide conformations in GNRA and UNCG type tetraloop hairpins: evidence from Raman markers assignments 10.1093/nar/27.5.1398

Structural features of the UCCG and UGCG tetraloops in very short hairpins as evidenced by optical spectroscopy 10.1021/bi980011t

Prochlorothrix hollandica PCC 9006: Genomic properties of an axenic representative of the chlorophyll a/b-containing oxyphotobacteria 10.1016/S0923-2508(97)81590-2

UNCG tetraloops in short oligoribonucleotides reveal high thermodynamic stability and unusual structural properties in aqueous phase as confirmed by optical and NMR spectroscopies 10.1016/S0022-2860(96)09536-1

Conformational studies by H-1 NMR of the HIV enhancer: The transcription factors NF-kappa B and Sp1 binding domains 10.1002/(SICI)1097-458X(199612)34:133.0.CO;2-F

Potential lipophilic nucleotide prodrugs: Synthesis, hydrolysis, and antiretroviral activity of AZT and d4T acyl nucleotides 10.1021/jo951354p

Synthesis of acylphosphates of purine ribonucleosides 10.1016/S0040-4039(96)02016-3

Chemienzymatic synthesis of uridine nucleotides labeled with [N-15] and [C-13] 10.1006/abio.1995.0007

SYNTHESIS OF ACYL PYROPHOSPHATES - APPLICATION TO THE SYNTHESIS OF NUCLEOTIDE LIPOPHILIC PRODRUGS 10.1016/0040-4039(94)02322-3

SYNTHESIS OF NUCLEOTIDE LIPOPHILIC PRODRUGS CONTAINING 2 INHIBITORS TARGETED AGAINST DIFFERENT PHASES OF THE HIV REPLICATION CYCLE 10.1080/15257779508012471

ENZYMATIC-SYNTHESIS OF DISACCHARIDE-SERINE AND PEPTIDE CONJUGATES 10.1016/S0960-894X(01)80708-3

ENZYMATIC-SYNTHESIS OF SOME O-BETA-D-DIGALACTOSYL GLYCOPEPTIDES, USING BETA-D-GALACTOSIDASE 10.1016/0008-6215(93)84137-U

INFLUENCE OF GLUCOSE ON THE DEOXYGLUCOSE METABOLISM IN SACCHAROMYCES-CEREVISIAE - DETECTION AND IDENTIFICATION OF DEOXYGLUCOSE AND TREHALOSE DERIVATIVES BY H-1-NMR AND C-13-NMR SPECTROSCOPY 10.1016/0300-9084(93)90134-E

BIOCHROMATOGRAPHY AND MOLECULAR-BIOLOGY - A REPORT ON THE 4TH EUROPEAN MEETING OF GFBC - BIOCHROMATOGRAPHY AND MOLECULAR-BIOLOGY, LA-GRANDE-MOTTE, FRANCE, 12-14 MAY, 1992 10.1016/0165-9936(92)87084-W

IMPROVED BRAIN DELIVERY OF AZT USING A GLYCOSYL PHOSPHOTRIESTER PRODRUG 10.1021/jm00094a018

H-1-NMR AND P-31-NMR STUDIES OF DITERCALINIUM BINDING TO A D(GCGC)2 AND D(CCTATAGG)2 MINIHELICES - A SEQUENCE SPECIFICITY STUDY 10.1002/bip.360310307

NEW FLUORESCENT AND PHOTOACTIVABLE ANALOGS ACTING ON NUCLEOTIDE BINDING ENZYMES 10.1016/S0040-4039(00)92285-8

SYNTHESIS OF FLUORESCEINYLATED 2'-DEOXYADENOSINE - MONOPHOSPHATE, DIPHOSPHATE AND TRIPHOSPHATE DERIVATIVES 10.1016/0040-4039(90)80130-E

SYNTHESIS OF TETRATHYMIDYLATES COVALENTLY LINKED TO ELLIPTICINE DERIVATIVES 10.1080/07328319008045105

SIMPLE CHEMICAL SYNTHESIS AND HYBRIDIZATION PROPERTIES OF NON-RADIOACTIVE DNA PROBES 10.1016/0300-9084(89)90003-5

SYNTHESIS OF FLUORESCENT OR BIOTINYLATED NUCLEOSIDE COMPOUNDS 10.1016/S0040-4020(01)81640-9

STRUCTURAL ANALOGS OF SEROTONIN AS AFFINITY MARKERS OF SEROTONINERGIC RECEPTORS 10.1016/S0040-4039(00)88925-X

Differential expression of Ixodes ricinus salivary gland proteins in the presence of the Borrelia burgdorferi sensu lato complex 10.1016/j.jprot.2013.10.033

Isolation, Functional Characterization and Proteomic Identification of CC2-PLA(2) from Cerastes cerastes Venom: A Basic Platelet-Aggregation-Inhibiting Factor 10.1007/s10930-013-9534-x

Proteomic Analysis of Intact Flagella of Procyclic Trypanosoma brucei Cells Identifies Novel Flagellar Proteins with Unique Sub-localization and Dynamics 10.1074/mcp.M113.033357

Cdc48-associated complex bound to 60S particles is required for the clearance of aberrant translation products 10.1073/pnas.1221724110

Rqc1 and Ltn1 Prevent C-terminal Alanine-Threonine Tail (CAT-tail)-induced Protein Aggregation by Efficient Recruitment of Cdc48 on Stalled 60S Subunits. 10.1074/jbc.M116.722264

Role of the N-Acetylmuramoyl-l-Alanyl Amidase, AmiA, of Helicobacter pylori in Peptidoglycan Metabolism, Daughter Cell Separation, and Virulence. 10.1089/mdr.2016.0070

The ribosome-bound quality control complex remains associated to aberrant peptides during their proteasomal targeting and interacts with Tom1 to limit protein aggregation 10.1091/mbc.E16-10-0746

Actin activates Pseudomonas aeruginosa ExoY nucleotidyl cyclase toxin and ExoY-like effector domains from MARTX toxins 10.1038/ncomms13582

The cryo-EM structure of a ribosome-Ski2-Ski3-Ski8 helicase complex 10.1126/science.aaf7520

Infection by chikungunya virus modulates the expression of several proteins in Aedes aegypti salivary glands 10.1186/1756-3305-5-264

A SKI subcomplex specifically required for the degradation of ribosome-free RNA regions 10.1101/409490

Detection and Degradation of Nonsense-mediated mRNA Decay Substrates Involve Two Distinct Upf1-bound Complexes 10.1101/266833

Nonsense‐mediated mRNA decay involves two distinct Upf1‐bound complexes 10.15252/embj.201899278

A specialised SKI complex assists the cytoplasmic RNA exosome in the absence of direct association with ribosomes 10.15252/embj.2018100640

Structural and functional insights into CWC27/CWC22 heterodimer linking the exon junction complex to spliceosomes. 10.1093/nar/gkaa267

Structural inventory of native ribosomal ABCE1-43S pre-initiation complexes 10.1101/2020.07.09.194902

A structural inventory of native ribosomal ABCE1‐43S pre‐initiation complexes 10.15252/embj.2020105179